![](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/2119066-526267035-190705-biontech-logo-rgb-dark-green-preferred-0-png-100x11.png)
BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update
Announced positive data from multiple mRNA cancer vaccine clinical trials, including topline results from the ongoing Phase 2 evaluating FixVac candidate BNT111 Launched updated variant-adapted COVID-19 vaccine in the European Union (“EU”), received …